Abstract-Effects of L-glutamine on acetylsalicylic acid (ASA)-induced gastric mucosal lesions were studied in mongrel dogs. It was confirmed that when oral ASA at 1.0 or 2.0 g per dog is given in two divided doses, there is severe and consistent dose-dependent mucosal damage in the glandular portion of the stomach in fasted dogs. However, when L-glutamine 2.0 or 4.0 g per dog in two divided doses is given concomitantly with ASA 2.0 g per dog orally, the gastric irritation is significantly inhibited. Instillation of 20 mM of ASA in 100 mM HCl solution into the Heidenhain pouch of Beagle dogs produced a significant loss of H+ from the pouch and a gain of Na+ in the lumen com pared with ASA-free controls.
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When L-glutamine (100 mM) was given concomitantly with ASA (20mM) into the pouch, changes of electrolyte fluxes in response to ASA alone were significantly suppressed. However, 50 mM of L-glutamine had no appreciable effect on acid back diffusion caused by ASA 20 mM. The amino acid itself had little effect on the ionic movement in the pouch. Gross bleeding from the pouch treated with ASA was never observed with the concomitant dosing of ASA and L-glutamine 50 or 100 mM.
We have already reported the marked inhibitory effect of L-glutamine on acetylsalicylic acid (ASA)-induced gastric irritation in normal, cirrhotic or pregnant rats, or in rats with a chronic gastric ulcer (1) (2) (3) (4) . It was experimentally determined that L-glutamine produces a dose-dependent inhibition of acid back diffusion in response to ASA in the rat stomach (2) (3) (4) (5) . As dogs are frequently used in the study of gastric problems related to ASA (6-9), our present work was an attempt to determine the effects of L-glutamine in this species. This report contains data on the potent effect of this amino acid in preventing the noxious effect of ASA on the gastric mucosa in normal dogs and on the acid back diffusion in response to ASA in the stomach of Heidenhain pouch Beagle dogs.
MATERIALS AND METHODS
ASA -lesion formation: Thirty-six male mongrel dogs, weighing 8-10 kg, were deprived of food but allowed free access to water from 10:00 a.m. until the end of the experiments.
ASA packed in a gelatin capsule was given orally to the dogs in the dose of 0.25, 0.5 or 1.0 g per dog at 6:00 p.m. of the same day. At 10:00 a.m. the next day, ASA in the same dose was given to these same dogs, i.e., the total dose of ASA was 0.5, 1.0 or 2.0 g per dog per day.
An overdose of sodium pentobarbital was given i.v. at 6:00 p.m. of the same day after the dogs had fasted from food for a total of 32 hr. The stomach of each dog was removed, inflated by pouring in one liter of 1 % formalin solution for 10 min, then incised along the greater curvature and examined for lesions which had developed in the glandular portion. The length of each lesion was measured, summed and arbitrarily divided into 7 degrees as a lesion index as follows. The gastric specimens were put into Bouin solution for histological study. To determine the effect of L-glutamine on ASA-induced gastric lesions, L-glutamine at 0.5, 1.0 or 2.0 g per dog was mixed well with ASA at 1.0 g per dog, packed in a gelatin capsule and then given orally to the dogs, twice at a 16 hr interval. As a control, lactose at 1.0 g per dog was mixed with ASA 1.0 g per dog and also given twice at the same interval.
Acid back diffusion: The methods used in this study were much the same as those employed by Davenport (8) Statistics: Student's t-test was employed to determine the statistical significance of both lesion index and difference of ionic flux.
RESULTS
Effects of L-glutamine on gastric lesions induced with ASA ASA, when given at 0.5 g per dog per day in two divided doses, induced no detectable injuries to the gastric mucosa in 2 fasted dogs. However, the dosing of 1 g of ASA per dog per day resulted in an apparent development of mucosal erosions either punctate or elongated, mainly in the oxyntic glandular area including the so-called "magenstrasse" and partly in the antrum. ASA at 2 g per dog per day induced much more severe and consistent irritation of gastric mucosa than that seen at 1 g per dog per day (Table 1) . Histologically, the damage proved to be superficial erosions and there was never penetration beyond the muscularis mucosa. L-glutamine, given together with ASA at 2 g per dog per day, produced a definite inhibition of ASA-induced gastric lesions in dogs, i.e., the inhibition rate was 25.5 %, 
DISCUSSION
These studies provide further data that oral ASA produces gastric mucosal damage in fasted dogs (6, 7). The incidence of ASA-induced gastric lesions reported herein was 100 and the severity of lesions was quite consistent in each animal. As in our previous work done in rats, L-glutamine, given together with ASA, produced a marked dose-dependent protection of the gastric mucosa against the irritative effects of ASA. The dose of L-glu tamine which inhibited ASA gastric lesions by about 40-60 % was equivalent or only double that of ASA.
Many substances, including ASA, are known to break down the gastric mucosal barrier and permit back diffusion of acid through the disrupted mucosa, resulting in gastric mucosal damage (11) . To our knowledge, only one substance, carbenoxolone Na, was found to inhibit acid back diffusion induced by human bile through the Heidenhain pouch of dogs, even though the drug did not affect the flux of Na+ (12) . In contrast to the data observed in dogs, carbenoxolone Na was not reported to exert any appreciable effect on acid back diffusion induced by intragastric instillation of taurocholic acid in man (13) .
We have already reported data that L-glutamine inhibits the back diffusion of H+ and Davenport (14) and Chvasta and Cooke (9) found that when a Heidenhain pouch of dogs was irrigated with 20 mM of ASA in a 100 mM HCI solution, the recovered fluid frequently contained blood, indicating a severe mucosal damage by the agent. We also found blood in the fluids recovered in periods 3, 4 and 5 after the ASA treatment. L glutamine given concomitantly with ASA at the dose level of 50 or 100 mM solution com pletely prevented this bleeding from the pouch. Therefore, this amino acid may to some extent inhibit ASA-induced gastric bleeding by a mechanism other than prevention of acid back diffusion, since the dose of 50 mM of L-glutamine did not result in any significant inhibition of acid back diffusion in response to ASA in acid solution.
In rats, the absorption of ASA from either the gastric mucosa or gastroduodenal mucosa and the resulting pharmacologic effects, such as the analgesic, antipyretic or anti-inflam matory effects, remained unchanged in the presence of L-glutamine (15) . We found in preliminary work that the absorption of ASA from Heidenhain pouch of dogs was not affected by the presence of L-glutamine in a dose which inhibited the back diffusion of acid and gastric bleeding in response to ASA. Thus, the therapeutic effect of ASA is apparently not influenced by a concomitant dosing of L-glutamine. Data from clinical studies on the concomitant administration of ASA and L-glutamine to patients with rheumatic diseases will be reported in a succeeding paper.
